Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 19 |
NetGPI | no | yes: 0, no: 19 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A0A3S7X5L3
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 20 |
GO:0043167 | ion binding | 2 | 20 |
GO:0043169 | cation binding | 3 | 20 |
GO:0046872 | metal ion binding | 4 | 20 |
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.555 |
CLV_PCSK_FUR_1 | 73 | 77 | PF00082 | 0.598 |
CLV_PCSK_KEX2_1 | 75 | 77 | PF00082 | 0.543 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.628 |
DEG_SCF_FBW7_2 | 33 | 40 | PF00400 | 0.442 |
DOC_MAPK_gen_1 | 82 | 91 | PF00069 | 0.499 |
DOC_PP4_MxPP_1 | 20 | 23 | PF00568 | 0.709 |
DOC_USP7_MATH_1 | 106 | 110 | PF00917 | 0.333 |
DOC_USP7_UBL2_3 | 82 | 86 | PF12436 | 0.501 |
DOC_WW_Pin1_4 | 33 | 38 | PF00397 | 0.370 |
LIG_14-3-3_CanoR_1 | 49 | 56 | PF00244 | 0.344 |
LIG_KLC1_Yacidic_2 | 40 | 45 | PF13176 | 0.344 |
LIG_LIR_Apic_2 | 50 | 56 | PF02991 | 0.330 |
LIG_LIR_Apic_2 | 67 | 71 | PF02991 | 0.571 |
LIG_LIR_Gen_1 | 16 | 25 | PF02991 | 0.682 |
LIG_Pex14_1 | 31 | 35 | PF04695 | 0.341 |
LIG_SH2_CRK | 68 | 72 | PF00017 | 0.574 |
LIG_SH2_SRC | 43 | 46 | PF00017 | 0.353 |
LIG_SH2_STAP1 | 17 | 21 | PF00017 | 0.527 |
LIG_SH2_STAT3 | 59 | 62 | PF00017 | 0.628 |
LIG_SH2_STAT5 | 35 | 38 | PF00017 | 0.348 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.308 |
LIG_SH2_STAT5 | 59 | 62 | PF00017 | 0.539 |
LIG_SH3_3 | 18 | 24 | PF00018 | 0.591 |
LIG_TRAF2_1 | 108 | 111 | PF00917 | 0.536 |
MOD_CK1_1 | 64 | 70 | PF00069 | 0.453 |
MOD_CK2_1 | 105 | 111 | PF00069 | 0.342 |
MOD_GlcNHglycan | 126 | 129 | PF01048 | 0.673 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.533 |
MOD_GSK3_1 | 57 | 64 | PF00069 | 0.571 |
MOD_GSK3_1 | 78 | 85 | PF00069 | 0.574 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.565 |
MOD_N-GLC_1 | 13 | 18 | PF02516 | 0.568 |
MOD_NEK2_1 | 61 | 66 | PF00069 | 0.529 |
MOD_PKA_2 | 48 | 54 | PF00069 | 0.344 |
MOD_Plk_1 | 13 | 19 | PF00069 | 0.569 |
MOD_Plk_1 | 57 | 63 | PF00069 | 0.636 |
MOD_ProDKin_1 | 33 | 39 | PF00069 | 0.370 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.557 |
TRG_ER_diArg_1 | 73 | 76 | PF00400 | 0.590 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4E5 | Leptomonas seymouri | 47% | 100% |
A0A0N0P975 | Leptomonas seymouri | 80% | 100% |
A0A0S4IT37 | Bodo saltans | 44% | 90% |
A0A1X0NLL7 | Trypanosomatidae | 45% | 98% |
A0A1X0NUY8 | Trypanosomatidae | 59% | 66% |
A0A3R7NZE2 | Trypanosoma rangeli | 40% | 90% |
A0A3S7X0B7 | Leishmania donovani | 46% | 100% |
A0A422NH81 | Trypanosoma rangeli | 63% | 74% |
A4HFD2 | Leishmania braziliensis | 46% | 100% |
A4HKG1 | Leishmania braziliensis | 87% | 100% |
A4I363 | Leishmania infantum | 46% | 100% |
A4I7Y9 | Leishmania infantum | 100% | 100% |
C9ZKV1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 99% |
D0AA56 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 93% |
E9ACZ0 | Leishmania major | 47% | 100% |
E9AYR5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 46% | 100% |
E9B2V0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
Q4Q5A6 | Leishmania major | 96% | 100% |